...
首页> 外文期刊>OncoTargets and therapy >MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1
【24h】

MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1

机译:miR-195-5p通过靶向yap1来抑制宫颈癌的恶性进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Our previous studies have shown that miR-195 is reduced in cervical cancer tissues, and that upregulation of miR-195 suppressed cervical cancer cell growth and induced a cell cycle block. In this study, we aimed to further elucidate the mechanism of action between miR-195-5p and Yes-associated protein 1 (YAP1) in the malignant progression of cervical cancer. Methods: MiR-195-5p and YAP1 were detected using qRT-PCR in cervical cancer cells transfected with miR-195-5p mimics or inhibitor. Cell proliferation, migration, and invasion ability were detected using MTT, wound healing, and transwell invasion assays. Dual luciferase reporter assay, qRT-PCR, and Western blot analysis were used to demonstrate that YAP1 was a target of miR-195-5p. Results: Our results showed that miR-195-5p is negatively correlated with YAP1 protein levels but not with mRNA expression. Moreover, upregulation of miR-195-5p by transient transfection with miR-195-5p mimics in HeLa and SiHa cells inhibited cell proliferation, migration ability, invasiveness, and the EMT. Conversely, miR-195-5p downregulation produced opposite results. In addition, multiple miRNA target prediction sites showed that YAP1 was a potential target gene; this was confirmed by dual luciferase assay. Rescue experiments further confirmed that YAP1 is involved in miR-195-5p-mediated inhibition of proliferation, migration ability, invasiveness, and the EMT of cervical cancer cells. Conclusion: Taken together, our data suggest that miR-195-5p may act as a tumor suppressor which could provide a theoretical basis for cervical cancer patient targeted therapy.
机译:目的:我们以前的研究表明,宫颈癌组织中的miR-195降低,并且miR-195的上调抑制了宫颈癌细胞生长并诱导了细胞周期块。在这项研究中,我们旨在进一步阐明MiR-195-5P和Yes相关蛋白1(YAP1)之间的作用机制在宫颈癌的恶性进展中。方法:使用QRT-PCR在用MiR-195-5P模拟物或抑制剂转染的宫颈癌细胞中检测miR-195-5P和YAP1。使用MTT,伤口愈合和Transwell Invasion测定检测细胞增殖,迁移和侵袭能力。双荧光素酶报告器测定,QRT-PCR和Western印迹分析用于证明YAP1是miR-195-5p的靶标。结果:我们的研究结果表明,MIR-195-5P与YAP1蛋白水平负相关,但不具有mRNA表达。此外,在Hela和Siha细胞中瞬变转染MiR-195-5P的上调抑制细胞增殖,迁移能力,侵犯力和EMT。相反,MIR-195-5P下调产生了相反的结果。此外,多个miRNA靶预测位点显示YAP1是潜在的靶基因;这是通过双荧光素酶测定证实的。救援实验进一步证实,YAP1参与MiR-195-5P介导的增殖,迁移能力,侵袭性和宫颈癌细胞的EMT。结论:在一起,我们的数据表明MIR-195-5P可以充当肿瘤抑制器,其可以为宫颈癌患者提供靶向治疗的理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号